Entrar/Registro  
HOME SPANISH
 
Cirugía y Cirujanos
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Cirugía y Cirujanos >Year 2011, Issue 2


Montalvo-Javé EE, García-Puig MA, Escalante-Tattersfield T, Peña-Sánchez J, Vázquez-Meza H, Ortega-Salgado JA
Biochemical analysis and lipid peroxidation in liver ischemic preconditioning
Cir Cir 2011; 79 (2)

Language: Español
References: 24
Page: 132-140
PDF: 437.05 Kb.


Full text




ABSTRACT

Background: Hepatic surgery requires, under diverse circumstances, periods of ischemia and reperfusion (I-R) such as those present in liver resection, hepatic injury, and liver transplantation. The objective of the present work was to conduct an experimental study to evaluate the effect of hepatic preconditioning (HPC) on modulation of the I-R injury.
Methods: Male Wistar rats were distributed into the following three study groups: group 1, simulated or sham; group 2, submitted to a 30-min period of total warm ischemia and a reperfusion phase, and group 3, in which we carried out 10-min preconditioning of warm ischemia and 10 min of reperfusion prior to the total ischemia period for a total of 60 min and the reperfusion phase. We obtained liver biopsies for thiobarbituric acid reactive substances (TBARS) (MDA, thiobarbituric acid adducts) and for blood sample determinations in serum of liver-cell enzymes such as alanine aminotransferase and aspartate aminotransferase during a 24-h time course.
Results: We observed a decrease in the variables studied in group 3 (HPC) as well as of serum liver enzymes and TBARS levels such as indirect oxidative stress indicators upon comparison with group 2 animals submitted to total hepatic I-R.
Conclusions: HPC is an efficient surgical strategy for decreasing the elevation of hepatic enzymes and indirect lipoperoxidation indicators in an I-R model. Controlled clinical studies should be performed to determine its functional properties and clinical applicability.


Key words: Ischemia-reperfusion injury, liver preconditioning, serum hepatic enzymes, free radicals.


REFERENCIAS

  1. Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 1994;178:454-458.

  2. Montalvo-Javé EE. Lesión por isquemia reperfusión y trauma hepático. Trauma 2008;11:92-100.

  3. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003;125:1480-1491.

  4. Montalvo-Javé E, Villegas-Álvarez F, Montalvo-Arenas C, Pena-Sánchez J, Gutiérrez-Vega R, Pina E. Liver transplantation: some advances in liver cancer, live liver donation, and cell transplantation. A literature review. Rev Gastroenterol Mex 2009;74:341-348.

  5. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003;18:891-902.

  6. Montalvo-Javé EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA. Factors in the pathophysiology of the liver ischemiareperfusion injury. J Surg Res 2008;147:153-159.

  7. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001;181:160-166.

  8. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.

  9. Cadenas E, Sies H. Oxidative stress: excited oxygen species and enzyme activity. Adv Enzyme Regul 1985;23:217-237.

  10. Glanemann M, Langrehr JM, Stange BJ, Neumann U, Settmacher U, Steinmuller T, et al. Clinical implications of hepatic preservation injury after adult liver transplantation. Am J Transplant 2003;3:1003-1009.

  11. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deriaz H, et al. Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989;209:211-218.

  12. Peralta C, Bulbena O, Xaus C, Prats N, Cutrin JC, Poli G, et al. Ischemic preconditioning: a defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 2002;73:1203-1211.

  13. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007;356:1545-1559.

  14. Montalvo-Javé EE, Pina E, Montalvo-Arenas C, Urrutia R, Benavente-Chenhalls L, Pena-Sánchez J, et al. Role of ischemic preconditioning in liver surgery and hepatic transplantation. J Gastrointest Surg 2009;13:2074-2083.

  15. Zentella-de Pina M, Sandoval-Montiel A, Serrano-Alessandri L, Montalvo-Javé E, Zentella-Dehesa A, Pina E. Ethanol-mediated oxidative changes in blood lipids and proteins are reversed by aspirin-like drugs. Arch Med Res 2007;38:269-275.

  16. Tadolini B, Fiorentini D, Landi L, Cabrini L. Lipid peroxidation. Definition of experimental conditions for selective study of the propagation and termination phases. Free Radic Res Commun 1989;5:245-252.

  17. Selzner N, Rudiger H, Graf R, Clavien PA. Protective strategies against ischemic injury of the liver. Gastroenterology 2003;125:917-936.

  18. Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA. Lselectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998;275:G1341-1352.

  19. Shin T, Kuboki S, Lentsch AB. Roles of nuclear factor-kappaB in postischemic liver. Hepatol Res 2008;38:429-440.

  20. Petrowsky H, Busuttil RW. Evolving surgical approaches in liver transplantation. Semin Liver Dis 2009;29:121-133.

  21. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843-850; discussion 851-852.

  22. Lesurtel M, Lehmann K, de Rougemont O, Clavien PA. Clamping techniques and protecting strategies in liver surgery. HPB (Oxford) 2009;11:290-295.

  23. Franchello A, Gilbo N, David E, Ricchiuti A, Romagnoli R, Cerutti E, et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant 2009;9:1629-1639.

  24. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, et al. The ischemic preconditioning paradox in deceased donor liver transplantation- evidence from a prospective randomized single blind clinical trial. Am J Transplant 2007;7:2788-2796.






>Journals >Cirugía y Cirujanos >Year 2011, Issue 2
 

· Journal Index 
· Links 






       
Copyright 2019